prt2527
·Code: PRT2527
prt2527: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Prelude Therapeutics Inc (PRLD) | Phase 1 |
Clinical Trials (1)
A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With Relapsed/Refractory Hematologic Malignancies
Frequently asked questions
Who is developing prt2527?
prt2527 is being developed by Prelude Therapeutics Inc.
How many clinical trials involve prt2527?
BioSniper tracks 1 clinical trial involving prt2527.
Get deeper analysis on prt2527
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis